News

Seven days in medicine: 14 to 20 November

BMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h6184 (Published 19 November 2015) Cite this as: BMJ 2015;351:h6184

Saturday 14th

Lucentis offers treatment alternative for diabetic retinopathy Injections into the eye with the drug ranibizumab (Lucentis) in people with diabetic retinopathy led to a mean improvement in visual acuity letter score of 2.8 (equivalent to an average of about half a line on an eye chart), compared with 0.2 in patients treated with standard laser treatment, meeting the pre-specified non-inferiority outcome of a study reported in JAMA. Patients who were treated with ranibizumab had less peripheral visual field loss, required fewer vitrectomies, and experienced less macular oedema than patients who had laser therapy. (See The BMJ’s full story at doi:10.1136/bmj.h6145.)

Sunday 15th

Colleges press government for NHS funding boost The NHS is “being pushed to breaking point” and requires the UK government to “front-load the £8bn [€11.4bn; $12.2bn] it has committed to the NHS this parliament in the next two years,” said Clare Marx, president of the Royal College of Surgeons, and Jane Dacre, president of the Royal College of Physicians, in a letter to the Sunday Times. “The settlements will determine whether our patients will receive less of the same, or if we will be able to transform the NHS and improve the way care is delivered,” they wrote. …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe